Kevin A. Lobo has been the CEO of Stryker Corporation since October 2012, bringing with him over 25 years of experience in the medical technology field. Before joining Stryker, he held significant roles at Johnson & Johnson, including running a...

Kevin A. Lobo has been the CEO of Stryker Corporation since October 2012, bringing with him over 25 years of experience in the medical technology field. Before joining Stryker, he held significant roles at Johnson & Johnson, including running a $4 billion business. Known for his hands-on approach, Kevin's compensation is closely tied to the company's performance, indicating his commitment to aligning the interests of executives with those of shareholders. In 2023, he earned about $20.1 million, highlighting his success in steering the company towards growth. As of March 2024, Kevin owned nearly 100,000 shares of Stryker, valued at over $42 million, showing his confidence in the company’s future. Under his leadership, Stryker has seen strong performance metrics, like operating income and cash flow, indicating a well-performing business. This trajectory makes Kevin an influential figure in the medical technology industry, focused on blending business strategy with a commitment to shareholder value.